CLINICAL_TRIALS
trial_result
· 2022-05-25
Clinical Trial Update: Measuring Ambulation, Motor, and Behavioral Outcomes With Post-Stroke Fluoxetine in Tanzania [Phase 2]
Summary
Phase 2 trial assessing post-stroke fluoxetine for ambulation, motor, and behavioral outcomes in Tanzania has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Massachusetts General Hospital | Conditions: Acute Stroke, Stroke, Ischemic | Phase 2 | Status: COMPLETED | Results posted: 2022-05-25